Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. RoundTable Healthcare deals ophthalmic biz Beaver-Visitec to TPG
RoundTable Healthcare Partners said today it sold its ophthalmic surgical device subsidiary Beaver-Visitec International Holdings to private investment firm TPG Capital for an undisclosed amount.
Waltham, Mass.-based BVI produces Beaver blades, Visitec cannulae and instruments, Merocel and Weck-Cel ophthalmic fluid management products and Wet-Field Eraser electrosurgery products, and operates 2 manufacturing plants with locations in the U.S. and the U.K. Read more
4. Bioventus sets terms on $150m IPO
Orthobiologics maker Bioventus today released terms for its $150 million initial public offering, looking to float 8.8 million shares at between $16 and $18 per share, with plans to list on the NASDAQ Global Market under the ticker “BIOV”.
At the midpoint of its proposed range, the company would command a fully diluted market value of $566 million, and proceeds from the round should generate between $141 and $159 million, according to an SEC filing from the company. Read more
3. Medtronic wins CE Mark for Guardian Connect mobile CGM
Medtronic said today it won CE Mark approval in the European union for its Guardian Connect mobile continuous glucose monitoring system.
The Fridley, Minn.-based medical giant said it is the 1st smartphone-enabled CGM system to win CE Mark approval for the company, and expects to launch the device on a country-by-country basis in the 2nd quarter of its fiscal year 2017. Read more
2. Mazor touts studies showing advantage of robotic assistance in MIS spinal procedures
Mazor Robotics said today it is releasing data from 2 new studies touting the benefits of robotic assistance and surgical guidance with its Renaissance device during minimally invasive spinal surgery procedures.
The company said it presented t the data at the 23rd International Meeting on Advanced Spine Techniques in Washington, D.C. Read more
1. Johnson & Johnson reports street-beating Q2, shares on track for record high
Health care giant Johnson & Johnson is on track to see record high shares after reporting a street-beating 2nd quarter, with shares rising almost 3% in premarket trading.
Johnson & Johnson reported profits of $4 billion, or $1.43 per share, on sales of $18.5 billion for the 3 months ended June 30. Read more
